Page last updated: 2024-08-16
vorinostat and sn 38
vorinostat has been researched along with sn 38 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Canzoneri, JC; Guerrant, W; Hood, R; Oyelere, AK; Patil, V; Yao, LP | 1 |
| Chen, Y; Li, J; Lu, W; Shen, Q; Su, M; Yu, X; Zhang, Q; Zhou, Y; Zhu, Q | 1 |
Other Studies
2 other study(ies) available for vorinostat and sn 38
| Article | Year |
|---|---|
Dual-acting histone deacetylase-topoisomerase I inhibitors.
Topics: Camptothecin; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type I; Drug Design; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Protein Isoforms; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2013 |
A series of camptothecin prodrugs exhibit HDAC inhibition activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Stability; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Isoenzymes; Mice; Prodrugs; Structure-Activity Relationship | 2018 |